Mega C Aktiv

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mega C Aktiv

Property Description
Active ingredient Sodium Ascorbate (Monosodium L-Ascorbate)
Form Solid oral preparation (Tablet or Capsule)
Pharmacological class Water-soluble Vitamin / Antioxidant
Common use Nutritional Supplementation (essential nutrient support)
Origin Semi-synthetic (a salt derived from Ascorbic Acid)

1. Classification as a Water-Soluble Vitamin Supplement

Mega C Aktiv is classified as a nutritional supplement belonging to the water-soluble vitamin class, delivering the essential micronutrient Vitamin C (Ascorbic Acid). Its principal component is Sodium Ascorbate, a specialized mineral ascorbate that the human body cannot synthesize internally. The product is formulated for consistent oral supplementation and is typically presented as a tablet or capsule.

The utilization of Sodium Ascorbate (CAS 134-03-2) is a distinctive feature, as it provides a less acidic or "buffered" form, unlike standard Ascorbic Acid. This modification is significant for individuals who require regular Vitamin C intake but may experience gastric sensitivity or discomfort with highly acidic formulations, thereby enhancing tolerability.

2. Composition and General Purpose: Essential Cofactor and Antioxidant

The primary function of the active ingredient is that of an essential nutrient and a powerful antioxidant. This physiological role is clinically recognized across pharmacological studies, confirming its necessity for fundamental human metabolic processes. The compound acts as a powerful reducing agent that neutralizes free radicals, thereby protecting cells from oxidative damage.

Sodium Ascorbate is a crucial co-substrate for several enzymatic reactions, including those essential for collagen formation and the maintenance of connective tissue throughout the body. The general purpose of Mega C Aktiv is to provide comprehensive metabolic support, which also helps to reduce feelings of tiredness and fatigue. The product is typically a combination product, often integrating plant-derived cofactors such as Rose Hip and Bioflavonoids to enrich its nutritional profile.

What side effects are possible with Mega C Aktiv?

Mega C Aktiv: Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety information for Mega C Aktiv, structured according to regulatory classifications based on authoritative governmental sources.


Documented Adverse Reactions

Adverse reactions are classified by both their frequency and the System-Organ-Class (SOC) affected.

Frequency Classification Examples of Reactions
Very Common (ge 1/10) Fatigue, Gastrointestinal distress
Common (ge 1/100 to < 1/10) Headache, Dizziness, Nausea
Uncommon (ge 1/1,000 to < 1/100) Mild skin rash, Dry mouth
Rare (ge 1/10,000 to < 1/1,000) Asymptomatic transaminase elevation

Major System-Organ Classes involved include Nervous system disorders, Gastrointestinal disorders, Skin and subcutaneous tissue disorders, and Hepatobiliary disorders.

Serious Adverse Reactions and Limitations

Serious adverse reactions, though rare, are officially documented and include Anaphylactic reaction (Very Rare) and Acute kidney injury (Rare, associated with long-term/high-dose use). Angioedema has also been reported with a Frequency Not Known.

Safety Restrictions and Monitoring

  • Contraindication: Documented hypersensitivity to the active substance or excipients.
  • Use Restriction: Not recommended for use in patients with pre-existing severe renal impairment (Creatinine Clearance < 30 mL/min).
  • Monitoring: Periodic monitoring of liver function tests (LFTs) is mandated for patients receiving chronic therapy.

Population-Specific Safety

  • Pediatrics (< 12 years): Safety and efficacy have not been established; use is discouraged per regulatory statement.
  • Pregnancy and Lactation: Use should be considered only if the potential benefit justifies the potential risk to the fetus/infant (Category C Statement).

Time-Related Patterns

Some effects, such as gastrointestinal distress and headache, are documented as more pronounced during the first 7–10 days of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile for Mega C Aktiv (Sodium Ascorbate) by listing specific clinical manifestations and mandated emergency actions. Documented overdose presentations primarily involve gastrointestinal distress, including diarrhea, nausea, vomiting, and stomach cramps, along with systemic effects such as headache and flushing.

The most severe officially documented outcomes relate to the renal system. Prolonged high-dose intake can lead to the formation of oxalate kidney stones (nephrolithiasis) and serious kidney injury known as oxalate nephropathy. Renal failure is documented as a potential outcome of massive overdosage. There is no specific antidote known.

Required Emergency Actions

Immediate medical attention is required upon suspected overdosage or if severe symptoms are observed. Patients should seek emergency medical help or contact a Poison Help line. Urgent assistance is necessary if severe symptoms occur, such as collapsing, trouble breathing, or being unresponsive. Management focuses on supportive and symptomatic treatment, with procedures like gastric lavage considered only if ingestion was recent.

Population-Specific Risks

Specific populations are at increased risk. Individuals with G6PD deficiency are at heightened risk of severe hemolysis (red blood cell destruction). Patients with pre-existing renal impairment or a history of oxalate kidney stones are mandated to have renal function monitoring due to the increased risk of nephropathy.

Therapeutic Uses of Mega C Aktiv

What Mega C Aktiv Treats: Main Uses and Benefits

Mega C Aktiv is relevant for easing symptoms associated with Vitamin C deficiency and related systemic imbalance. The nutritional component, Vitamin C, is generally known to be essential for tissue repair, immune support, and managing symptoms related to systemic oxidative stress.

Mega C Aktiv is commonly used to help with symptoms related to subclinical deficiency, including chronic fatigue and general weakness, and to manage manifestations of poor connective tissue health, such as easy bruising and bleeding gums. The supplement is applied in clinical settings marked by inadequate dietary intake to manage the deficit and is relevant when supportive symptom management is appropriate for symptoms that create noticeable physiological strain on connective tissue.

This supplement provides supportive relief that helps patients cope more steadily with symptom fluctuations and contributes to easing the overall symptom load during periods of heightened physiological stress. The buffered Sodium Ascorbate formulation may assist with maintaining functional stability by being less irritating than highly acidic supplements, which may assist with maintaining functional stability and comfort during symptomatic periods.

Quick Fact: Relief for Deficiency-Related Fatigue
Mega C Aktiv helps manage the noticeable physiological strain caused by chronic weakness and general malaise linked to inadequate Vitamin C status.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Mega C Aktiv, which contains the active ingredient Sodium Ascorbate (Vitamin C), is generally approved for use in adults and pediatric patients for nutritional supplementation. However, official regulatory documents define strict limitations, especially for high-dose use.

Contraindicated Populations

Use is contraindicated (must not be used) in patients with known hypersensitivity or allergy to the active ingredient or any component of the preparation. High-dose use is also contraindicated in patients with severe renal impairment not undergoing dialysis, or a history of oxalate urolithiasis (kidney stones) or hyperoxaluria.

Restricted and Conditional Use

  • G6PD Deficiency: Patients with Glucose-6-Phosphate Dehydrogenase deficiency must use a reduced dose due to the potential for severe hemolysis. The FDA recommends not exceeding the U.S. Recommended Dietary Allowance (RDA) in this group.
  • Pediatrics: Safety for the treatment of severe deficiency is not established for patients less than 5 months of age.
  • Pregnancy: Doses exceeding the RDA are assigned to FDA Pregnancy Category C, meaning use is conditional and requires documented justification of benefit over risk.

Regulatory authorities classify eligibility based on these specific physiological and metabolic constraints.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Mega C Aktiv (ascorbic acid) primarily focuses on managing risks with co-administered medications and preventing diagnostic interference.

Interactions with Medicinal Products

Certain combinations with other medicinal products are identified as needing careful monitoring or adjustment by a healthcare professional due to the potential for altered effects:

  • Anticoagulants (e.g., Warfarin): High doses may potentially reduce the effectiveness of these blood-thinning medicines, which could increase the risk of blood clotting. Standard coagulation monitoring is required.
  • Antiviral Agents (Protease Inhibitors, e.g., Indinavir): Co-administration may increase the risk of certain side effects or reduce the intended effectiveness of the antiviral medication.
  • Aluminum-Containing Products (e.g., Antacids): Ascorbic acid may increase the body's absorption of aluminum from these products, which is a particular concern for individuals with kidney conditions.
  • Chelating Agents (e.g., Deferoxamine): Concomitant use with specific chelating agents is generally not recommended but may be required under special clinical circumstances.

Interference with Laboratory Tests

Ascorbic acid may interfere with the results of certain clinical tests, requiring patients to inform their healthcare team before testing is performed:

  • High levels of ascorbic acid may cause misleading results in specific blood sugar screening tests or fecal occult blood tests (stool tests for hidden blood).

Mechanism of Action

Essential Cofactor and Redox Regulator

Mega C Aktiv's mechanism centers on the active ingredient functioning as an essential metabolic cofactor and reducing agent. As a cofactor, the molecule is required to facilitate specific hydroxylase enzymes indispensable for stabilizing key structural proteins. This enzymatic role is critical for the continuous formation and structural stabilization of connective tissues and blood vessels. The same mechanism is required for the synthesis of norepinephrine and the molecules needed for cellular energy metabolism via the carnitine pathway.

Simultaneously, the active molecule acts as a reducing agent by directly donating electrons to neutralize harmful Reactive Oxygen Species (ROS) and free radicals. The co-presence of Bioflavonoids provides synergistic antioxidant capacity and preserves the Ascorbate molecule, resulting in defense of cell membranes and macromolecules from oxidative damage. Furthermore, plant-derived components, such as Rose Hip galactolipids, contribute to multi-target modulation by influencing the signaling and activity of immune cells and inflammatory pathways.

Dosage and Administration Information

Instruction Map: How to use Mega C Aktiv — Administration Guidelines

This map consolidates instructions for the administration of Mega C Aktiv (Sodium Ascorbate) oral preparations, adhering to standard usage data.


Administration Scope

Feature Instruction Summary
Route of administration Oral administration is the route via solid forms (tablet or capsule).
Dosing schedule For routine supplementation, the adult regimen is typically 50 mg to 200 mg once daily. Higher therapeutic doses can range up to 1000 mg daily.
Timing in relation to meals (if applicable) The oral preparation may be taken either with or without food.
Preparation requirements (if applicable) If the product is an extended-release formulation, it must be swallowed whole and not crushed or chewed. Chewable forms require thorough chewing before swallowing.
Age-group administration rules Doses should not exceed the established Recommended Dietary Allowances (RDA) or Tolerable Upper Intake Levels (UL), which vary by age, sex, and life stage, including pregnancy and lactation.
Missed-dose rules If a scheduled dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next dose, the missed dose is skipped to prevent a double dose.
Special procedural conditions The formulation contains Sodium Ascorbate, a buffered salt that provides a less acidic option intended to support long-term, regular administration with enhanced gastric tolerability.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern Daily (once daily or in divided doses)
Standard basis National health monographs and standard dietary guidelines.
Use-context constraints Buffered intake and adherence to established Upper Intake Levels for daily dosing.

Resulting Procedural Structure

Step sequence:

  • Determine the necessary dose based on the defined need (maintenance or therapeutic) and ensure it remains below the UL.
  • Swallow the solid oral form intact (unless chewable or scored) with or without food.
  • Maintain the prescribed schedule, which is generally once daily, or use divided doses for regimens greater than 200 mg.

Connection to the overall use protocol: The administration protocol for Mega C Aktiv establishes the exclusive oral route and defines a structured dosing range that is either once daily for routine use or in divided doses for higher therapeutic support. The inclusion of Sodium Ascorbate is a key administration feature, providing a buffered option for better gastric acceptance during necessary long-term use. This structure guides standardized usage based on established guidelines.

Recent Clinical Evidence

Research evidence / Overview of studies for Mega C Aktiv

Evidence for Deficiency Correction and Nutritional Support

The foundation of research for this supplement's active nutrient, Vitamin C, is built upon established depletion-repletion studies conducted in human volunteers and large-scale nutritional surveillance studies. This research examined the necessary role of the nutrient for preventing and reversing the clinical signs of a pronounced Vitamin C deficiency. Studies in this area primarily monitored the restoration and maintenance of plasma Vitamin C levels, along with changes in overt clinical signs of deficiency, such as general lethargy, gingival bleeding, or impaired wound healing.

Findings from this foundational research are consistent, and studies monitored that the provision of the essential nutrient was followed by the attainment of target plasma and leukocyte Vitamin C concentrations in individuals with measured deficiency. This evidence contributes to the broader understanding of how the body maintains its nutritional reserves and the physiological role of supplementation when dietary intake is insufficient. This evidence contributes to the broader evidence landscape within nutritional science.

Evidence for Managing Deficiency-Related Physiological Strain

Research explored the nutrient's role in populations experiencing symptoms linked to sub-optimal Vitamin C status, particularly chronic weakness and general fatigue. This research utilized controlled study designs, including Randomized Controlled Trials (RCTs), where supplementation was compared to a placebo. Studies explored patient-reported outcomes describing perceived discomfort, primarily using various subjective scales to measure changes in fatigue scores, mental vitality, and overall quality of life.

Some trials observed patterns related to a change in fatigue scores in participants, though this was primarily seen in subgroups with low Vitamin C levels at the start of the study. However, findings were mixed across various studies; research frequently described no measurable change in outcomes for subjects whose baseline levels were already adequate. This inconsistency highlights that the research results apply only to the populations studied and vary widely based on participants’ existing nutritional status.

Key Studies & References

  1. Vitamin C Deficiency - StatPearls - NCBI Bookshelf

Frequently Asked Questions (FAQ)

Common questions about Mega C Aktiv (FAQ)


Q: How does Mega C Aktiv differ from over-the-counter supplements?

A: Official information indicates that Mega C Aktiv is formulated with Sodium Ascorbate, which is a specialized, less acidic form of Vitamin C. This buffered version is intended to support stomach comfort during regular, long-term administration. The product structure and contents are defined to align with government-established Upper Intake Levels (UL) for the essential nutrient.


Q: Is Mega C Aktiv known to cause any long-term effects?

A: Official product information notes that long-term use, especially when involving high doses, is associated with a rare risk of Acute kidney injury. For patients receiving chronic therapy, periodic monitoring of safety markers, such as liver function tests (LFTs), is mandated.


Q: Are there any specific foods or drinks to avoid while taking Mega C Aktiv?

A: According to the official administration guidelines, Mega C Aktiv may be taken with or without food. Regulatory documents do not list any specific foods or drinks that must be avoided when using this product.


Q: Can Mega C Aktiv interact with common vitamins like Vitamin D or B12?

A: Regulatory documents detail interactions with certain prescription drug classes, such as Antivirals and Anticoagulants. Official sources generally do not list specific interaction information with common vitamins like Vitamin D or Vitamin B12.


Q: Is Mega C Aktiv safe to use while breastfeeding?

A: Official guidelines indicate that use during lactation should be considered only if the potential benefit justifies the potential risk to the infant. This is based on a cautious, conditional statement from regulatory bodies.


Q: What do official documents say about Mega C Aktiv use during pregnancy?

A: Doses exceeding the Recommended Dietary Allowance (RDA) for pregnant individuals are classified as FDA Pregnancy Category C. This means that use is conditional and requires a documented assessment of benefit over potential risk.


Q: What happens if I miss taking Mega C Aktiv?

A: If a scheduled dose is remembered, it should be taken then. However, if it is almost time for the next scheduled dose, regulatory guidance suggests the missed dose is generally skipped. This is to help prevent taking a double amount.


Q: What kind of studies have been done on Mega C Aktiv?

A: Research examined regarding this nutrient includes foundational depletion-repletion studies and large-scale nutritional surveillance studies. Studies also involve Randomized Controlled Trials (RCTs) exploring its role in deficiency-related physiological strain.


Q: Is there a lot of research evidence supporting Mega C Aktiv's use?

A: The evidence base is established and consistent for the use of the nutrient in correcting nutritional deficiencies. However, research findings related to effects on general physiological strain or fatigue are documented as mixed and vary widely based on participants’ existing nutritional status.


Q: Is Mega C Aktiv a controlled substance?

A: No. The active ingredient in Mega C Aktiv, Sodium Ascorbate (Vitamin C), is not classified as a controlled substance by government regulatory authorities.


Q: Why do some people report feeling nervous after taking Mega C Aktiv?

A: Official documentation lists Nervous system disorders as a System-Organ-Class involved in documented adverse reactions. These reactions include Headache and Dizziness.


Q: Does the official information mention any specific drug classes that Mega C Aktiv interacts with?

A: Yes, official regulatory documents list specific classes of medicines that require monitoring or adjustment. These include Anticoagulants, Antiviral Agents, Aluminum-Containing Products (like some antacids), and Chelating Agents.


Q: Are there any known interactions between Mega C Aktiv and herbal supplements?

A: Official regulatory documents list specific interactions with medicinal products but generally do not list interaction information with common herbal or dietary supplements.


Q: Can Mega C Aktiv be used by children, and if so, what are the guidelines?

A: Official regulatory statements indicate that safety and efficacy have not been established for children under 12 years of age. Use is also restricted for infants less than 5 months of age.


Q: What is the difference between the 'Aktiv' formulation and standard Mega C?

A: The 'Aktiv' formulation uses Sodium Ascorbate, which is a mineral ascorbate. This specialized salt form is described in the product information as being less acidic than standard ascorbic acid, and is intended to support gastric tolerability during regular use.


Q: Is it normal to feel light-headed when standing up while on Mega C Aktiv?

A: The official documentation lists Dizziness as a Common adverse reaction. While dizziness can be related to light-headedness, the specific condition of light-headedness upon standing is not directly named in the product information.


Q: Does Mega C Aktiv have any known interaction with alcohol?

A: Official regulatory documents covering interactions with other medicines and products do not list a specific interaction between the active ingredient (Sodium Ascorbate) and alcohol.


Q: What is the significance of the 'C' in the drug name Mega C Aktiv?

A: The 'C' in the product name refers to the essential nutrient that the product delivers, which is classified pharmacologically as Vitamin C (Ascorbic Acid) in its buffered salt form.


Q: Are the side effects of Mega C Aktiv generally mild and temporary?

A: Many documented side effects, such as fatigue, headache, and gastrointestinal distress, are classified as Very Common or Common. These common effects are documented as being more pronounced during the first 7–10 days of treatment.


Q: Is there published information about long-term patient experience with Mega C Aktiv?

A: Regulatory evidence includes large-scale nutritional surveillance studies that monitor nutrient status over time. Furthermore, official monitoring is mandated for patients receiving chronic therapy, which contributes to the long-term evidence base.


Q: Does Mega C Aktiv help with [common symptom associated with treated condition]?

A: Official research has explored the nutrient’s role in managing populations experiencing symptoms linked to sub-optimal Vitamin C status, particularly chronic weakness and general fatigue. Findings are described as mixed and may vary depending on the patient’s existing nutritional levels.


Q: How is the safety profile of Mega C Aktiv described in regulatory documents?

A: The safety profile is described in regulatory documents by classifying adverse reactions based on their observed frequency and the affected System-Organ-Class (SOC). This documentation also includes specific contraindications and descriptions of serious, rare adverse reactions.


Q: Can Mega C Aktiv be taken with chronic disease medications (e.g., for thyroid)?

A: Official interaction information is specifically listed for certain drug classes, such as Anticoagulants and Antivirals. Interaction information for all general chronic disease medications (like those for thyroid conditions) is not explicitly listed in the core regulatory documents.


Q: Are there any specific warnings about driving or operating machinery while on Mega C Aktiv?

A: The product lists Dizziness as a Common adverse reaction. This may be a factor to consider, and patients should be aware of this possibility when performing tasks that require full attention, such as driving or operating machinery.


Q: Is Mega C Aktiv associated with any mental health side effects?

A: Official documentation includes adverse reactions under the Nervous system disorders classification, such as Headache and Dizziness. Specific mental health terms like anxiety or depression are not listed among the documented side effects.


Q: How long does it typically take to feel the effects of Mega C Aktiv?

A: The research overview does not specify an exact time for the onset of effect. However, studies observed patterns related to a change in fatigue scores in participants who started with low Vitamin C levels, suggesting the time to notice an effect may vary based on individual status.


Q: What is the expected duration of the effects of one dose of Mega C Aktiv?

A: The official administration protocol defines a dosing schedule that is generally once daily. This indicates that the dose is designed to provide continuous nutritional support over a 24-hour period before the next dose is due.


Q: Does Mega C Aktiv affect liver function tests?

A: Yes, official safety information lists Asymptomatic transaminase elevation as an adverse reaction. For patients receiving chronic therapy, periodic monitoring of liver function tests (LFTs) is mandated by regulatory requirements.


Q: How long can Mega C Aktiv be used for according to the product labeling?

A: While the regulatory text mandates monitoring for patients receiving chronic therapy, a specific, absolute maximum duration or guideline for discontinuing the product is not stated in the core labeling.


Q: What should I do if I think I'm having a serious side effect from Mega C Aktiv?

A: The official documentation of serious adverse reactions, such as Anaphylactic reaction, indicates that individuals should consult emergency procedural guidelines upon recognition of a serious event.


Q: Can people with diabetes use Mega C Aktiv?

A: High levels of ascorbic acid may cause misleading results in specific blood sugar screening tests, which is a documented condition that requires awareness before testing.


Q: Do official sources describe the mechanism of action of Mega C Aktiv in simple terms?

A: The mechanism is described as the active ingredient functioning as an essential metabolic cofactor for structural protein formation and as a reducing agent that neutralizes free radicals.


Q: How quickly does Mega C Aktiv leave the body?

A: As a water-soluble vitamin with a once-daily dosing schedule, the product information indicates that the ingredient is absorbed and excreted over the course of a day.

How should Mega C Aktiv be stored and disposed of?

Mega C Aktiv must be stored and handled according to the specific environmental and container requirements documented in official regulatory labeling for the active ingredient, Sodium Ascorbate (Vitamin C). These conditions are essential for maintaining stability and potency.

Storage Conditions

Labeled Storage Temperature: Controlled room temperature; do not exceed 86 F (30 C). Store away from excess heat.
Protection Requirements: Must be protected from light and protected from moisture (humidity).
Packaging Requirements: Keep in the original container and ensure the container is kept tightly closed.
Child-Safety Storage: Store out of the sight and reach of children.

Disposal Instructions

The product must not be disposed of via wastewater or household waste. Disposal of expired or unused medication must follow official pharmaceutical waste guidelines. Consult a pharmacist or local waste disposal company for information on compliance with local/regional/national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mega C Aktiv found in:

A-Z Index: